Assessment of type I interferon response in routine practice in France in 2022

An European Alliance of Associations for Rheumatology task force recently recommended specific points to consider for exploring type I interferon pathway in patients, highlighting the lack of analytical assays validated for clinical routine. We report here the French experience on a type I interfero...

Descripción completa

Detalles Bibliográficos
Autores principales: Nombel, Anais, Foray, Anne Perrine, Garnier, Lorna, Lombard, Christine, Hachulla, Eric, Bader-Meunier, Brigitte, Georgin-Lavialle, Sophie, Melki, Isabelle, Walzer, Thierry, Belot, Alexandre, Viel, Sebastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Miscellaneous
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277519/
https://www.ncbi.nlm.nih.gov/pubmed/37321666
http://dx.doi.org/10.1136/rmdopen-2023-003211
_version_ 1785060300076089344
author Nombel, Anais
Foray, Anne Perrine
Garnier, Lorna
Lombard, Christine
Hachulla, Eric
Bader-Meunier, Brigitte
Georgin-Lavialle, Sophie
Melki, Isabelle
Walzer, Thierry
Belot, Alexandre
Viel, Sebastien
author_facet Nombel, Anais
Foray, Anne Perrine
Garnier, Lorna
Lombard, Christine
Hachulla, Eric
Bader-Meunier, Brigitte
Georgin-Lavialle, Sophie
Melki, Isabelle
Walzer, Thierry
Belot, Alexandre
Viel, Sebastien
author_sort Nombel, Anais
collection PubMed
description An European Alliance of Associations for Rheumatology task force recently recommended specific points to consider for exploring type I interferon pathway in patients, highlighting the lack of analytical assays validated for clinical routine. We report here the French experience on a type I interferon pathway assay that has been set up and used routinely since 2018 in Lyon, France.
format Online
Article
Text
id pubmed-10277519
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-102775192023-06-20 Assessment of type I interferon response in routine practice in France in 2022 Nombel, Anais Foray, Anne Perrine Garnier, Lorna Lombard, Christine Hachulla, Eric Bader-Meunier, Brigitte Georgin-Lavialle, Sophie Melki, Isabelle Walzer, Thierry Belot, Alexandre Viel, Sebastien RMD Open Miscellaneous An European Alliance of Associations for Rheumatology task force recently recommended specific points to consider for exploring type I interferon pathway in patients, highlighting the lack of analytical assays validated for clinical routine. We report here the French experience on a type I interferon pathway assay that has been set up and used routinely since 2018 in Lyon, France. BMJ Publishing Group 2023-06-15 /pmc/articles/PMC10277519/ /pubmed/37321666 http://dx.doi.org/10.1136/rmdopen-2023-003211 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Miscellaneous
Nombel, Anais
Foray, Anne Perrine
Garnier, Lorna
Lombard, Christine
Hachulla, Eric
Bader-Meunier, Brigitte
Georgin-Lavialle, Sophie
Melki, Isabelle
Walzer, Thierry
Belot, Alexandre
Viel, Sebastien
Assessment of type I interferon response in routine practice in France in 2022
title Assessment of type I interferon response in routine practice in France in 2022
title_full Assessment of type I interferon response in routine practice in France in 2022
title_fullStr Assessment of type I interferon response in routine practice in France in 2022
title_full_unstemmed Assessment of type I interferon response in routine practice in France in 2022
title_short Assessment of type I interferon response in routine practice in France in 2022
title_sort assessment of type i interferon response in routine practice in france in 2022
topic Miscellaneous
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277519/
https://www.ncbi.nlm.nih.gov/pubmed/37321666
http://dx.doi.org/10.1136/rmdopen-2023-003211
work_keys_str_mv AT nombelanais assessmentoftypeiinterferonresponseinroutinepracticeinfrancein2022
AT forayanneperrine assessmentoftypeiinterferonresponseinroutinepracticeinfrancein2022
AT garnierlorna assessmentoftypeiinterferonresponseinroutinepracticeinfrancein2022
AT lombardchristine assessmentoftypeiinterferonresponseinroutinepracticeinfrancein2022
AT hachullaeric assessmentoftypeiinterferonresponseinroutinepracticeinfrancein2022
AT badermeunierbrigitte assessmentoftypeiinterferonresponseinroutinepracticeinfrancein2022
AT georginlaviallesophie assessmentoftypeiinterferonresponseinroutinepracticeinfrancein2022
AT melkiisabelle assessmentoftypeiinterferonresponseinroutinepracticeinfrancein2022
AT walzerthierry assessmentoftypeiinterferonresponseinroutinepracticeinfrancein2022
AT belotalexandre assessmentoftypeiinterferonresponseinroutinepracticeinfrancein2022
AT vielsebastien assessmentoftypeiinterferonresponseinroutinepracticeinfrancein2022

Ejemplares similares